Carticept Medical gets $20M in Series B Financing

By

Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $20 million Series B financing round. New investor SonoSite, Inc. joined existing investors Domain Associates and New Enterprise Associates. The financing will provide funding for the expected commercial launch of the Company’s NavigatorTM Delivery System, an integrated, computer-controlled, fluid delivery system designed to automate the delivery of medication for the benefit of both the patient and physician, as well to complete patie...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.